The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Inhibition of pancreatic lipase in vitro by the covalent inhibitor tetrahydrolipstatin
Open accessAbstract
Tetrahydrolipstatin inhibits pancreatic lipase from several species, including man, with comparable potency. The lipase is progressively inactivated through the formation of a long-lived covalent intermediate, probably with a 1:1 stoichiometry. The lipase substrate triolein and also a boronic acid derivative, which is presumed to be a transition-state-form inhibitor, retard the rate of inactivation. Therefore, in all probability, tetrahydrolipstatin reacts with pancreatic lipase at, or near, the substrate binding or active site. Tetrahydrolipstatin is a selective inhibitor of lipase; other hydrolases tested were at least a thousand times less potently inhibited.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
The preparation and properties of two new chromogenic substrates of trypsin
Erlanger, B. F., Kokowsky, N., & Cohen, W. (1961) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(61)90145-x · Cited by 3,353
Esters of Methanesulfonic Acid as Irreversible Inhibitors of Acetylcholinesterase
Kitz, R., & Wilson, I. B. (1962) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)50153-8 · Cited by 1,519
Watching Fat Digestion: The formation of visible product phases by pancreatic lipase is described.
Patton, J. S., & Carey, M. C. (1979) · Science · doi:10.1126/science.432636 · Cited by 384
WEIBEL, E. K., HADVARY, P., HOCHULI, E., KUPFER, E., & LENGSFELD, H. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1081 · Cited by 341
Self-citationMatthews, D. A., Alden, R. A., Birktoft, J. J., Freer, S. T., & Kraut, J. (1975) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)40917-4 · Cited by 221
Hochuli, E., KUPFER, E., MAURER, R., Meister, W., MERCADAL, Y., & Schmidt, K. W. (1987) · The Journal of Antibiotics · doi:10.7164/antibiotics.40.1086 · Cited by 146
Lipase, colipase, amphipathic dietary proteins, and bile acids: New interactions at an old interface
Hofmann, A. F. (1978) · Gastroenterology · doi:10.1016/0016-5085(78)90866-1 · Cited by 24
Cited by
How were new medicines discovered?
Swinney, D. C., & Anthony, J. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3480 · Cited by 1,812
Bacterial lipases: an overview of production, purification and biochemical properties
Gupta, R., Gupta, N., & Rathi, P. (2004) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-004-1568-8 · Cited by 1,178
Klein, S., Burke, L. E., Bray, G. A., Blair, S., Allison, D. B., Pi-Sunyer, X., Hong, Y., & Eckel, R. H. (2004) · Circulation · doi:10.1161/01.cir.0000145546.97738.1e · Cited by 934
Possible anti-obesity therapeutics from nature--a review
Yun, J. W. (2010) · Phytochemistry · doi:10.1016/j.phytochem.2010.07.011 · Cited by 619
Orlistat, a New Lipase Inhibitor for the Management of Obesity
Heck, A. M., Yanovski, J. A., & Calis, K. A. (2000) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.4.270.34882 · Cited by 572
The Metabolic Serine Hydrolases and Their Functions in Mammalian Physiology and Disease
Long, J. Z., & Cravatt, B. F. (2011) · Chemical Reviews · doi:10.1021/cr200075y · Cited by 425
Signaling pathways in obesity: mechanisms and therapeutic interventions
Wen, X., Zhang, B., Wu, B., Xiao, H., Li, Z., Li, R., Xu, X., & Li, T. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01149-x · Cited by 410
Current and Potential Drugs for Treatment of Obesity
Bray, G. A., & Greenway, F. L. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0383 · Cited by 331
Ros, E. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(00)00456-1 · Cited by 316
Anesthetic Considerations for Bariatric Surgery
Ogunnaike, B. O., Jones, S. B., Jones, D. B., Provost, D., & Whitten, C. W. (2002) · Anesthesia & Analgesia · doi:10.1097/00000539-200212000-00061 · Cited by 293
Electrophilic natural products and their biological targets
Gersch, M., Kreuzer, J., & Sieber, S. A. (2012) · Natural Product Reports · doi:10.1039/c2np20012k · Cited by 282
Hadváry, P., Sidler, W., Meister, W., Vetter, W., & Wolfer, H. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)52203-1 · Cited by 280
Self-citationAGA technical review on obesity
Klein, S., Wadden, T., & Sugerman, H. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35514 · Cited by 274
Jamal, Z., Martin, A., Gomez-Muñoz, A., & Brindley, D. N. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)49945-0 · Cited by 274
Theory and Applications of Covalent Docking in Drug Discovery: Merits and Pitfalls
Kumalo, H., Bhakat, S., & Soliman, M. (2015) · Molecules · doi:10.3390/molecules20021984 · Cited by 158
Orlistat Inhibits Dietary Cholesterol Absorption
Mittendorfer, B., Ostlund, R. E., Patterson, B. W., & Klein, S. (2001) · Obesity Research · doi:10.1038/oby.2001.79 · Cited by 114
Michaelsen, M. H., Wasan, K. M., Sivak, O., Müllertz, A., & Rades, T. (2016) · The AAPS Journal · doi:10.1208/s12248-015-9832-7 · Cited by 55
“However, it is also possible that the in vivo lipase activity is not fully inhibited by the amount of orlistat dosed; orlistat is inhibiting the pancreatic lipase at a stoichiometry of around 1:1 (31).”
Hadrich, F., Cher, S., Gargouri, Y. T., & Adel, S. (2014) · Journal of Oleo Science · doi:10.5650/jos.ess13163 · Cited by 49
Fabbrini, E., & Klein, S. (2008) · Clinical Cornerstone · doi:10.1016/s1098-3597(08)60027-7 · Cited by 9
Metadata
- Authors
- Hadváry, P., Lengsfeld, H., & Wolfer, H.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1988-12-01
- Volume
- 256
- Issue
- 2
- Pages
- 357-361
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1939955036
- Cited by
- 345
- References
- 8
- FWCI
- 1.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.